← Back to Search

Mindfulness Training for Gambling Addiction

N/A
Waitlist Available
Led By Jon E Grant, JD, MD, MPH
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between the ages of 18 and 29 at intake
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

Study Summary

This trial will help researchers learn more about what causes gambling addiction.

Who is the study for?
This trial is for young adults aged 18 to 29 who have gambled at least five times in the past year and can understand the study procedures enough to give written consent. It's not suitable for those unable to comprehend the study or provide consent.Check my eligibility
What is being tested?
The study aims to identify risk factors for developing pathological gambling by using mindfulness techniques and cognitive assessments as interventions.See study design
What are the potential side effects?
Since this trial involves non-invasive methods like mindfulness practices and cognition evaluations, there are typically no direct physical side effects associated with these interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 29 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Structured Clinical Interview for Pathological Gambling (SCI-PG)

Trial Design

3Treatment groups
Active Control
Group I: CognitionActive Control1 Intervention
Cognitive training and psychoeducation
Group II: ControlActive Control1 Intervention
Psychoeducation
Group III: MindfulnessActive Control1 Intervention
Mindfulness activity and psychoeducation

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,001 Previous Clinical Trials
817,142 Total Patients Enrolled
Jon E Grant, JD, MD, MPHPrincipal InvestigatorUniversity of Chicago, Department of Psychiatry
7 Previous Clinical Trials
289 Total Patients Enrolled

Media Library

Cognition Clinical Trial Eligibility Overview. Trial Name: NCT01528982 — N/A
Gambling Addiction Research Study Groups: Cognition, Control, Mindfulness
Gambling Addiction Clinical Trial 2023: Cognition Highlights & Side Effects. Trial Name: NCT01528982 — N/A
Cognition 2023 Treatment Timeline for Medical Study. Trial Name: NCT01528982 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Susceptibility to Pathological Gambling
2008. "Susceptibility to Pathological Gambling". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01528982.
~18 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top